Lantus Should Not Be Given with Novolog 70/30
Insulin glargine (Lantus) should not be mixed with other forms of insulin, including Novolog 70/30, due to the low pH of its diluent which can affect the pharmacokinetics of other insulins. 1
Rationale for Not Mixing Lantus with Other Insulins
- Insulin glargine has a unique formulation with an acidic pH (4.0) that is essential for its stability and prolonged action profile 2
- When mixed with other insulins, physicochemical changes can occur that alter the pharmacokinetic properties of both insulins, potentially leading to unpredictable glucose control 1
- The American Diabetes Association explicitly states that insulin glargine should not be mixed with other forms of insulin 1
- The FDA label for Lantus specifically warns against diluting or mixing Lantus with any other insulin or solution 3
Proper Administration of These Insulins
- Lantus (insulin glargine) should be administered as a separate injection once daily at the same time each day 3
- Novolog 70/30 (insulin aspart protamine/insulin aspart) is typically administered twice daily, before breakfast and dinner 4, 5
- When using both types of insulin in a regimen, they should be administered as separate injections 1, 3
Clinical Implications
- Using both insulins in a regimen (but as separate injections) can provide complementary coverage:
- Premixed insulins like Novolog 70/30 offer the advantage of fewer daily injections while providing both basal and prandial coverage 4, 5
- Basal insulins like Lantus may be used in combination with premixed insulins, but must be administered separately 1
Potential Alternatives
- If simplification of the regimen is desired, consider:
- When switching between insulin regimens, maintain the same total daily dose initially but adjust the distribution appropriately 7
- More frequent blood glucose monitoring is essential during any transition period between insulin regimens 7, 8
Common Pitfalls to Avoid
- Never mix Lantus in the same syringe with any other insulin 1, 3
- Avoid converting between insulin regimens on a 1:1 basis without considering appropriate dose adjustments 7, 8
- Don't neglect more frequent blood glucose monitoring during transition periods between insulin regimens 7
- Remember that meal timing becomes more critical with premixed insulins compared to basal-bolus regimens 7, 8